About Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE(1)
Cyanokit is indicated for the treatment of known or suspected cyanide poisoning. If clinical suspicion of cyanide poisoning is high, Cyanokit should be administered without delay.
Important Safety Information
Prior to administration of Cyanokit, smoke-inhalation victims should be assessed for: exposure to fire or smoke in an enclosed area; presence of soot around the mouth, nose or oropharynx; altered mental status.
Use caution in the management of patients with known anaphylactic reactions to hydroxocobalamin or cyanocobalamin. Allergic reactions may include: anaphylaxis, chest tightness, edema, urticaria, pruritus, dyspnea, and rash.
Most common adverse reactions (>5%) are transient and include chromaturia (red-colored urine), erythema (skin redness), rash, increased blood pressure, nausea, headache, decreased lymphocyte percent, and injection site reactions. Usage may interfere with some clinical laboratory evaluations.
If the decision is made to administer another antidote with Cyanokit, these drugs should not be administered in the same IV line. The safety of simultaneous administration has not been established.
Please see full Prescribing Information at http://www.cyanokit.com or call 800-755-5560 and ask for Customer Service.
About Dey, L.P.
Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), is a specialty
pharmaceutical company focused on the development, manufacturing and
|SOURCE Dey, L.P.|
Copyright©2008 PR Newswire.
All rights reserved